Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy
NCT ID: NCT00505505
Last Updated: 2008-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
800 participants
INTERVENTIONAL
2002-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia
NCT00993057
Supraphysiologic Insulin to Improve Outcomes After Surgical Treatment of Unruptured Cerebral Aneurysms
NCT00615381
Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic Stroke
NCT02054429
Normoglycemia and Neurological Outcome
NCT01137773
Severe Intraoperative Hyperglycemia During Craniotomy and Postoperative Infections
NCT02165748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Insulin infusion rate titrated to maintain glycemia between 80 and 100 mg/dl
Insulin (Actrapid)
50 UI Actrapid diluted in 50 ml of saline
B
Insulin infusion rate titrated to maintain glycemia between 80 and 220 mg/dl
Insulin (Actrapid)
50 UI Actrapid diluted in 50 ml of saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insulin (Actrapid)
50 UI Actrapid diluted in 50 ml of saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Traumatic brain injury
* Intracranial hemorrhage
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Roma La Sapienza
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Federico Bilotta, MD, PhD
Role: STUDY_CHAIR
Department of Anesthesiology, Critical Care and Pain Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rome La Sapienza
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Vincenzo Cuzzone
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1781964
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.